BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21973210)

  • 1. Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity.
    Dullaart RP; Vergeer M; de Vries R; Kappelle PJ; Dallinga-Thie GM
    J Intern Med; 2012 May; 271(5):490-8. PubMed ID: 21973210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.
    de Vries R; Kappelle PJ; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):253-9. PubMed ID: 21481395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
    Dullaart RP; De Vries R; Scheek L; Borggreve SE; Van Gent T; Dallinga-Thie GM; Ito M; Nagano M; Sluiter WJ; Hattori H; Van Tol A
    Scand J Clin Lab Invest; 2004; 64(3):205-15. PubMed ID: 15222630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation.
    Gruppen EG; Kersten S; Dullaart RPF
    Lipids Health Dis; 2018 Mar; 17(1):60. PubMed ID: 29587751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
    de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
    Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.
    Tzotzas T; Desrumaux C; Lagrost L
    Obes Rev; 2009 Jul; 10(4):403-11. PubMed ID: 19413703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
    Dullaart RP; Garcia E; Jeyarajah E; Gruppen EG; Connelly MA
    Lipids Health Dis; 2016 Aug; 15(1):143. PubMed ID: 27581838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease.
    Nass KJ; van den Berg EH; Gruppen EG; Dullaart RPF
    Eur J Clin Invest; 2018 Sep; 48(9):e12988. PubMed ID: 29947103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
    Dallinga-Thie GM; van Tol A; Dullaart RP;
    Biochim Biophys Acta; 2009 Aug; 1791(8):714-8. PubMed ID: 19303940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
    Dullaart RPF; Gruppen EG; Dallinga-Thie GM
    Clin Biochem; 2016 Apr; 49(6):508-510. PubMed ID: 26656640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.
    Vergeer M; Boekholdt SM; Sandhu MS; Ricketts SL; Wareham NJ; Brown MJ; de Faire U; Leander K; Gigante B; Kavousi M; Hofman A; Uitterlinden AG; van Duijn CM; Witteman JC; Jukema JW; Schadt EE; van der Schoot E; Kastelein JJ; Khaw KT; Dullaart RP; van Tol A; Trip MD; Dallinga-Thie GM
    Circulation; 2010 Aug; 122(5):470-7. PubMed ID: 20644014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid transfer protein activity and incident type 2 diabetes mellitus.
    Abbasi A; Dallinga-Thie GM; Dullaart RP
    Clin Chim Acta; 2015 Jan; 439():38-41. PubMed ID: 25304745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Wong WK; Tam S
    Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?
    Dallinga-Thie GM; van Tol A; Hattori H; Rensen PC; Sijbrands EJ
    Diabetes; 2006 May; 55(5):1491-6. PubMed ID: 16644710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y; Tam S
    Atherosclerosis; 2005 Feb; 178(2):365-70. PubMed ID: 15754464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.
    Guay SP; Brisson D; Lamarche B; Gaudet D; Bouchard L
    Epigenetics; 2014 May; 9(5):718-29. PubMed ID: 24504152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.
    Schlitt A; Schwaab B; Fingscheidt K; Lackner KJ; Heine GH; Vogt A; Buerke M; Maegdefessel L; Raaz U; Werdan K; Jiang XC
    Lipids; 2010 Feb; 45(2):129-35. PubMed ID: 20108050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.